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We report four Indonesian cases meeting the clinical and radiological criteria for community-acquired pneumonia and other
findings suggestive of leptospirosis. Quantitative PCR (qPCR) analyses of serum and urine samples and serology confirmed the
diagnosis of leptospirosis in each. Results of qPCR analysis of throat swabs were concordant with those obtained with acute-
phase serum samples, which suggests its potential for use as a noninvasive diagnostic tool for leptospirosis.
Pulmonary involvement in leptospirosis varies from atypicalsymptoms to severe pulmonary hemorrhage. However, pneu-
monia is not commonly associated with leptospirosis (1). We re-
port four cases of laboratory-confirmed leptospirosis clinically
presentingwith community-acquired pneumonia (CAP) during a
CAP study involving 148 subjects in Semarang, Indonesia, from
October 2007 to April 2009. These patients had other findings
suggesting leptospirosis (2) and were positive by commercial
rapid tests.
For confirmation of leptospirosis, microscopic agglutination
test (MATs) and enzyme-linked immunosorbent assays (ELISAs)
of (paired) serum samples were performed (3) and qPCR analyses
of sputum, throat swab, serum, and urine samples were per-
formed (4). Throat swab, first serum, and urine samples were
taken on the day of admission; convalescent-phase serum sam-
ples were taken 2 to 4 weeks after admission. Samples were refrig-
erated at 80°C. DNA was extracted with NucliSens easyMAG
(bioMérieux, Zaltbommel, The Netherlands). Negative controls
were used. Infection with common CAP pathogens, including
Chlamydia pneumoniae, C. psittaci, Mycoplasma pneumoniae, Le-
gionella pneumophila, influenza virus, parainfluenza virus, respi-
ratory syncytial virus, adenovirus, rhinovirus, coronaviruses
(2293E, OC43, and NL63), metapneumovirus, Streptococcus
pneumoniae, and other bacteria, was investigated with a wide
range of microbiological tests. Written informed consent for the
publication of this case series was obtained from the individuals
described.
Case 1. A 65-year-old woman presented in a tertiary-care hos-
pital in Semarang, Indonesia, with 4 days of fever (39°C), a dry
cough, and dyspnea (respiratory rate [RR], 32 breaths/min), con-
junctival suffusion, and crackles in her lungs. Her white blood cell
(WBC) count was 12,600/l, and her thrombocyte count (TC)
was 20,000/l. A chest X-ray (CXR) showed lung infiltrates. CAP
was diagnosed with a pneumonia severity index (PSI) score (5) of
135. She recovered after therapy with ceftriaxone. Diagnostic tests
for other CAP pathogens were all negative. An ELISA for leptospi-
rosis showed significant increases in IgM and total immunoglob-
ulin (IgT). A MAT showed seroconversion for serovar Bataviae.
Real-time quantitative PCR (qPCR) assays of acute-phase serum,
urine, and throat swab samples were positive, but a qPCR assay of
convalescent-phase serumwas negative (Table 1). Amplicons had
a melting temperature (Tm) of 80.5°C.
Case 2. A 58-year-old male had 4 days of fever, a dry cough,
dyspnea (RR, 28 breaths/min), icteric sclerae, and crackles over
the right lower lung. His WBC count was 6,800/l, his TC was
101,000/l, and his creatinine level was 1.68 mg/dl. A CXR con-
firmed lung infiltrates. CAP was diagnosed with a PSI score of 78.
He recovered after therapy with ceftriaxone. An ELISA showed
increased IgM and IgT titers; a MAT showed seroconversion for
serovar Bataviae. qPCR assays of acute-phase serum and throat
swab samples were positive (Tm 80.5°C), but qPCR assays of urine
and convalescent-phase serum samples were negative. Other mi-
crobiology tests were negative, except for a rhinovirus PCR assay.
Case 3. A 72-year-old male had 7 days of fever, a dry cough,
dyspnea, icteric sclerae, petechiae, and gum bleeding. Crackles
were heard over the lungs. His WBC count was 11,700/l, his TC
was 45,000/l, his serum alanine aminotransferase level was 104
U/liter, his total bilirubin level was 4.01 mg/dl, and his creatinine
level was 1.68 mg/dl. A CXR showed lung infiltrates. CAP was
diagnosed with a PSI score of 92. He recovered after therapy with
cefotaxime followed by oral doxycycline. AMAT showed serocon-
version for serovar Bataviae. Leptospira qPCR assays of acute-
phase serum and throat swab samples were positive (Tm 80.5°C),
but those of urine, sputum, and convalescent-phase serum sam-
ples were negative. Serology tests also showed seroconversion of
IgM antibody to C. pneumoniae; however, this finding was con-
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sidered inconclusive since the clinical presentation did not sup-
port C. pneumoniae pneumonia and PCR assays for C. pneu-
moniae and C. psittaci were negative.
Case 4. A 33-year-old male had 4 days of fever, a nonproductive
cough, dyspnea, icteric sclerae, and conjunctival suffusion. Calf ten-
dernesswas found; crackleswereheard inboth lungs.HisWBCcount
was 12,300/l, his TC was 21,000/l, his blood urea level was 288.0
mg/dl, his creatinine level was 7.02mg/dl, and his total bilirubin level
was 4.85 mg/dl. A CXR showed infiltrates in his lungs. CAP was di-
agnosedwith aPSI scoreof 83.He recovered after therapywith ceftri-
axone. AMAT and an ELISA of the single serum sample were incon-
clusive. qPCRassays of serumand throat swab sampleswere positive.
Other microbiology tests were negative.
In all four cases, results of qPCR assays of throat swab samples
correlated with those of acute-phase serum samples but not with
those of sputum or convalescent-phase serum samples, implying
the presence of Leptospira in the upper respiratory tract in the
acute phase of the disease. All qPCR products from throat swab,
serum, or urine samples had a Tm of 80.5°C, consistent with Lep-
tospira interrogans serovar Bataviae reference strain Swart and, in
turn, were in concordance with the observed seroconversions for
serovar Bataviae.
Leptospires from pulmonary tissue may reach the throat via
expectorated sputum, but only one patient produced sputum that
was, however, negative by qPCR assay. Further research is needed
to confirm the consistent presence of leptospires in the throat in
the acute phase.
Our findings suggest that pathogenic Leptospira, detected by
qPCR assay,may be causative of CAP. The finding of rhinovirus in
case 2 indicates a coinfection, which is a common finding among
CAP patients (6).
Leptospira bacteria appear in the urine 7 days after the onset of
the disease but are occasionally found in early urine samples (7).
Consistently, a qPCR assay of one of the four urine samples was
positive. While qPCR analysis of acute-phase urine samples lacks
the sensitivity required for early diagnosis, throat swabs consis-
tently provided confirmation at this stage of the disease. Hence,
qPCR analysis of early throat swab samples might present a po-
tentially interesting novel noninvasive diagnostic approach.
Pulmonary radiographic alterations, usually bilaterally, in lep-
tospirosis have been frequently reported before. These patterns
are not specific and can be ascribed to pulmonary hemorrhages or
pneumonia in general (7). The patients described here may have
suffered from leptospirosis with pulmonary involvement of pneu-
monia or pulmonary hemorrhage and therefore were diagnosed
as having CAP at admission. However, leptospirosis with pulmo-
nary hemorrhages has a high mortality rate (30 to 60%) (1),
whereas our four patients survived and did not have bleeding
manifestations, except for case 3. Thus, the CXR patterns in our
cases could be regarded more as pneumonia. CAP due to lepto-
spirosis was reported previously, but the diagnosis was supported
by a MAT only (8).
In conclusion, patients with leptospirosis may present with signs
and symptoms compatible with CAP. In areas where leptospirosis is
endemic, the disease should be included in the differential diagnosis
of patients with CAP. qPCR analysis of throat swab samples is a po-
tential novel tool for the early diagnosis of leptospirosis.
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